[{"Assets_0_Q3_USD":24906730.0,"CommonStockSharesOutstanding_0_Q3_shares":42172090.0,"NetIncomeLoss_3_Q3_USD":-8305831.0,"NetIncomeLoss_1_Q3_USD":-3610085.0,"StockholdersEquity_0_Q3_USD":23452159.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170807"}]